ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 100 filers reported holding ENDOCYTE INC in Q3 2013. The put-call ratio across all filers is 15.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,416,000 | +28.7% | 79,731 | 0.0% | 0.00% | – |
| Q2 2018 | $1,100,000 | +42.3% | 79,731 | -6.2% | 0.00% | – |
| Q1 2018 | $773,000 | +112.4% | 85,031 | 0.0% | 0.00% | – |
| Q4 2017 | $364,000 | +203.3% | 85,031 | 0.0% | 0.00% | – |
| Q3 2017 | $120,000 | -18.4% | 85,031 | -13.5% | 0.00% | – |
| Q2 2017 | $147,000 | -21.8% | 98,313 | +34.1% | 0.00% | – |
| Q1 2017 | $188,000 | +93.8% | 73,310 | +92.9% | 0.00% | – |
| Q4 2016 | $97,000 | -8.5% | 38,010 | +10.8% | 0.00% | – |
| Q3 2016 | $106,000 | +7.1% | 34,310 | +11.0% | 0.00% | – |
| Q2 2016 | $99,000 | +3.1% | 30,910 | 0.0% | 0.00% | – |
| Q1 2016 | $96,000 | -22.6% | 30,910 | 0.0% | 0.00% | – |
| Q4 2015 | $124,000 | -13.3% | 30,910 | -1.0% | 0.00% | – |
| Q3 2015 | $143,000 | -59.1% | 31,210 | -53.8% | 0.00% | – |
| Q2 2015 | $350,000 | -13.8% | 67,484 | +4.1% | 0.00% | – |
| Q1 2015 | $406,000 | +10.0% | 64,854 | +10.6% | 0.00% | – |
| Q4 2014 | $369,000 | +18350.0% | 58,654 | +19451.3% | 0.00% | – |
| Q3 2014 | $2,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2014 | $2,000 | -71.4% | 300 | 0.0% | 0.00% | – |
| Q1 2014 | $7,000 | -99.6% | 300 | -99.8% | 0.00% | -100.0% |
| Q4 2013 | $1,601,000 | -41.2% | 149,769 | -26.7% | 0.00% | -50.0% |
| Q3 2013 | $2,724,000 | -0.3% | 204,303 | -1.8% | 0.00% | -33.3% |
| Q2 2013 | $2,732,000 | – | 208,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|